Intellia Therapeutics NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Market Optimism MTRX Q1 2026 Earnings Strong EPS Beat Signals Operational Momentum MAXN Q4 2024 Earnings Massive Earnings Beat Signals Operational Improvement Amidst Solar Headwinds CYRX Q1 2026 Earnings EPS Miss Reflects Persistent Cost Pressures GEHC Q1 2026 Earnings Profit Misses Estimates Amid Operational Headwinds SSC Technologies Q1 2026 Earnings Slight EPS Beat Amid Steady Operations